Towa Pharmaceutical , Ltd. Receivables

Towa Pharmaceutical , Ltd. (TWAPF) currently reports a receivables of $75B as of June 2026. That compares with $59B in the prior-year period — up 27.3% year over year. Use the charts on this page to explore Towa Pharmaceutical , Ltd.'s receivables history and peer comparisons.

Towa Pharmaceutical , Ltd.'s receivables increased from $59B to $75B — a 27.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Towa Pharmaceutical , Ltd. reported $75B in receivables as of June 2026. That compares with $59B in the prior-year period — up 27.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $75B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Towa Pharmaceutical , Ltd., and consider following TWAPF for alerts when major investors trade the stock.